RBC Capital Reiterates Outperform on Perspective Therapeutics, Maintains $16 Price Target

Perspective Therapeutics, Inc. Common Stock +2.64%

Perspective Therapeutics, Inc. Common Stock

CATX

3.11

+2.64%

RBC Capital analyst Gregory Renza reiterates Perspective Therapeutics (AMEX: CATX) with a Outperform and maintains $16 price target.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via